National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance | Zendy

Lauren G. Gilstrap | Zendy; Ateev Mehrotra | Zendy; Barbara Bai | Zendy; Sherri Rose | Zendy; Rachel Blair | Zendy; Michael E. Chernew | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

National Rates of Initiation and Intensification of Antidiabetic Therapy Among Patients With Commercial Insurance

Author(s) -

Lauren G. Gilstrap,

Ateev Mehrotra,

Barbara Bai,

Sherri Rose,

Rachel Blair,

Michael E. Chernew

Publication year - 2018

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc17-2585

Subject(s) - medicine , cohort , diabetes mellitus , logistic regression , pharmacy , drug , cohort study , type 2 diabetes , retrospective cohort study , pharmacology , endocrinology , family medicine

Prompt initiation and intensification of antidiabetic therapy can delay or prevent complications from diabetes. We sought to understand the rates of and factors associated with the initiation and intensification of antidiabetic therapy among commercially insured patients in the U.S.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research